Andrew is a patent agent with significant experience helping companies generate, manage, and protect intellectual property assets. Focusing on biotechnology, he regularly provides services including intellectual property strategy, patent searches, competitive landscaping, freedom-to-operate opinions, patent preparation, and patent prosecution to innovative companies in the life sciences, medical technology, and the renewable energy sectors.
Prior to joining Mintz, Andrew was a patent agent with an intellectual property law firm in Chicago, where he drafted patents, provided IP estate analyses, and delivered IP research services. He has drafted and prosecuted patents for technologies including metabolic and genetic engineering of industrially-important microorganisms; integrated chemical processes for solvent and polymer production; simulated moving bed chromatography for separation and purification of natural products; biomedical and bioanalytical devices; and optical probing of precancerous cells based on differential backscattering signals.
Andrew has more than 20 years of experience leading and managing biotechnology projects, and a strong track record of successfully conceptualizing, leading, and completing metabolic engineering R&D projects that provide a strong patent position and lead to commercial deployment. He has worked as a technical advisor and director on numerous R&D and IP matters, both as an independent consultant and in-house for commercial operations. Andrew spent nine years working in scientific and advisory positions at renewable bioenergy company Coskata, Inc., and eight years with biotechnology research and development company Fermalogic, where he was a senior scientist, principal investigator, and later director of R&D. He also worked as a post-doctoral scientist in the Strain and Fermentation Development Group at Abbott Laboratories.
- University of Illinois - Urbana-Champaign (PhD, Microbiology)
- University of Illinois - Urbana-Champaign (MS, Microbiology)
- Queens College of the City of New York (BA, Biology)
Andrew is inventor on 13 issued patents and seven pending applications.
- US Patent 9,790,522 | Compositions and methods for the conversion of short-chain carboxylic acids and alcohols using Clostridial enzymes.
- US Patent 9,464,302 | Methods for sustaining the viability of acetogens during a decrease or cessation of syngas flow.
- US Patent 9,428,755 | Use of novel methyltransferases for generating novel strains.
- US Patent 9,284,528 | Genes encoding key catalyzing mechanisms for ethanol production from syngas fermentation.
- US Patent 9,045,760 | Genes encoding key catalyzing mechanisms for ethanol production from syngas fermentation.
- US patent 9,045,758 | Use of novel methyltransferases for generating novel strains.
- US patent 9,040,268 | Method for controlling undesirable byproducts formation caused by contaminating organisms in the production of ethanol from syngas.
- US Patent 9,034,617 | Processes for the anaerobic bioconversion of syngas to oxygenated organic compounds with in situ protection from hydrogen cyanide.
- US patent 8,987,431 | Essential genes encoding conserved metabolic pathway function in autotrophic solventogenic Clostridial species.
- US patent 8,628,943 | Genes encoding key catalyzing mechanisms for ethanol production from syngas fermentation.
- US patent 8,551,746 | Method for controlling undesirable by-products formation caused by contaminating organisms in the production of ethanol from syngas.
- US patent 8,039,239 | Recombinant microorganisms having modified production of alcohols and acids.
- US patent 7,638,306 | Process of increasing cellular production of biologically active compounds.
Patent applications pending
- US Appl. No. 14/680,195 | Compositions and methods for the conversion of short-chained carboxylic acids to alcohols using clostridial enzymes.
- US Appl. No. 14/812,182 | Syntrophic co-culture of anaerobic microorganisms for production of n-butanol from syngas.
- US Appl. No. 12/157,978 | Identification of contaminating bacteria in industrial ethanol fermentations.
- US Appl. No. 11/466,364 | Methods of increasing production of secondary metabolites by manipulating metabolic pathways that include methylmalonyl-CoA.
- US Appl. No. 11/566,155 | Methods of creating consumable strains and compositions thereof.
- US Appl. No. 12/614,976 | Process of increasing cellular production of biologically active compounds.
- US Appl. No. 12/468,456 | Process of increasing cellular production of biologically active compounds.